Advertisement

Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Document › Details

Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin.

Organisations Organisation Bayer Pharma AG
  Group Bayer (Group)
  Organisation 2 Kandy Therapeutics Ltd.
Products Product NT-814 (NeRRe Therapeutics / KaNDy Therapeutics)
  Product 2 women’s health
Index term Index term Kandy Therapeutics–Bayer: investment, 202008– acquisition $425m upfront + $450m developm milestones + triple digit $m sales milestones
Persons Person Oelrich, Stefan (Bayer 201811– Head of Pharma division before Sanofi Head of Diabetes + Cardiovascular)
  Person 2 Kerr, Mary (Nerre Therapeutics 201510– CEO before GSK + Advent Life Sciences)
     


   
Record changed: 2020-09-04

Advertisement

Picture [iito] No Tracking 650x80px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top